carbapenems has been researched along with sy 5555 in 33 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (sy 5555) | Trials (sy 5555) | Recent Studies (post-2010) (sy 5555) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 35 | 18 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.09) | 18.7374 |
| 1990's | 30 (90.91) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeGuchi, Y; Terasaki, T; Tsuji, A; Yamada, H | 1 |
| Bergan, T; da Fonseca, J | 1 |
| Ishiguro, M; Iwata, H; Tanaka, R | 1 |
| Nord, CE; Norrby, SR; Rylander, M | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Adachi, H; Ishiguro, M; Koizuka, S; Maeda, Y; Nishihara, T; Nishino, T; Ohtsu, E; Okamoto, K | 1 |
| Barry, AL; Fuchs, PC; Sewell, DL | 1 |
| Allen, S; Barry, A; Fuchs, P; McLaughlin, J; Pfaller, M; Sewell, D | 1 |
| Cormican, MG; Jones, RN | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
| Iwai, N; Nakamura, H | 1 |
| Hayakawa, F; Itomi, K; Kato, T; Kuno, K; Miyajima, Y; Ogawa, A; Okumura, A; Takahashi, H | 1 |
| Ihara, T; Itoh, M; Kamiya, H; Kitamura, K; Nakano, T; Sakurai, M | 1 |
| Abe, T; Hagiwara, N; Hata, M; Iitsuka, T; Kobayashi, M; Kubota, K; Kudou, S; Nakayama, T; Negishi, S; Tajima, T | 1 |
| Fujii, R; Meguro, H; Terashima, I | 1 |
| Kuwahata, K; Niinou, K; Sato, H; Sigeta, M; Suzuki, H | 1 |
| Ishihara, T; Nakamura, H; Tezuka, T; Toyonaga, Y | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K; Yokota, T | 1 |
| Aoki, S; Nishimura, T; Sugita, K; Takagi, M | 1 |
| Higashino, H; Kino, M; Kobayashi, Y | 1 |
| Haruta, T; Kobayashi, Y | 1 |
| Furukawa, S; Okada, T | 1 |
| Okamoto, T; Sekiguchi, T | 1 |
| Hamada, F; Kurashige, T; Nagao, A; Okada, T; Wakiguchi, H; Watanabe, S | 1 |
| Handa, S; Imai, S; Kato, H; Motohiro, T; Oda, K; Oki, S; Sakata, Y; Yamada, S; Yamashita, F; Yoshinaga, Y | 1 |
| Fukuda, T; Gondou, I; Harada, Y; Hayashi, K; Kido, T; Kobayashi, N; Matsumoto, T; Tsuji, Y; Uchida, T; Uehara, Y | 1 |
| Inoue, E; Mitsuhashi, S | 1 |
| Adachi, H; Ishiguro, M; Nakatsuka, T; Namikawa, K; Sugita, O; Tanaka, R; Yoshida, T | 1 |
| Abe, T; Fujii, R; Meguro, H; Nakamura, H; Niino, K; Sato, H; Suzuki, H; Tajima, T; Terashima, I; Toyonaga, Y | 1 |
| Arakawa, S; Hirose, T; Kamidono, S; Kumamoto, Y; Kumazawa, J; Matsumoto, T; Nishimura, M | 1 |
| Egleton, JH; Mortensen, JE | 1 |
| Andrews, JM; Ashby, JP; Brenwald, NP; Wise, R; Woodcock, JM | 1 |
18 trial(s) available for carbapenems and sy 5555
| Article | Year |
|---|---|
[Laboratory and clinical studies on SY5555 in pediatrics].
Topics: Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Half-Life; Humans; Impetigo; Infant; Male; Microbial Sensitivity Tests; Patient Compliance; Respiratory Tract Infections; Urinary Tract Infections | 1995 |
[Clinical studies on SY5555 in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Diarrhea; Eosinophilia; Female; Humans; Infant; Male; Respiratory Tract Infections; Scarlet Fever; Urinary Tract Infections | 1995 |
[Studies on SY5555 in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1995 |
[Pharmacokinetic, bacteriological, and clinical studies on SY5555 in children].
Topics: Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1995 |
[Clinical evaluation of a new oral penem, SY5555, in the pediatric field].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Diarrhea; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Urinary Tract Infections | 1995 |
[Clinical studies on SY5555 in pediatric infections].
Topics: Administration, Oral; Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections; Scarlet Fever; Urinary Tract Infections | 1995 |
[Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
Topics: Absorption; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
[Fundamental and clinical studies of SY5555 in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests | 1995 |
[Bacteriological and clinical studies of SY5555 in pediatric field].
Topics: Administration, Oral; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1995 |
[Clinical evaluation of a new oral penem, SY5555, in infants and children].
Topics: Administration, Oral; Adolescent; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Staphylococcus aureus; Streptococcus pyogenes | 1995 |
[Clinical study of SY5555 dry syrup in the pediatric field].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Male | 1995 |
[A clinical evaluation of SY5555 in the treatment of pediatric infections].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1995 |
[Clinical studies on SY5555 in pediatrics].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Powders; Tablets | 1995 |
[Clinical and laboratory studies on SY5555 in pediatric infectious diseases].
Topics: Administration, Oral; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1995 |
[Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Powders | 1995 |
[Pharmacokinetic and clinical studies on SY5555 dry syrup in children].
Topics: Administration, Oral; Bacterial Infections; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male | 1995 |
[Pharmacokinetic and clinical studies of SY5555 in the pediatric field. Pediatric Study Group of SY5555].
Topics: Absorption; Adolescent; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Dosage Forms; Female; Half-Life; Humans; Infant; Japan; Male; Tablets | 1994 |
[Fundamental and clinical studies on MIC breakpoint of SY5555 for Enterococcus faecalis in complicated urinary tract infections of moderate severity].
Topics: Adult; Carbapenems; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections | 1994 |
15 other study(ies) available for carbapenems and sy 5555
| Article | Year |
|---|---|
An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Carbapenems; Cephamycins; Dialysis; Extracellular Space; Liver; Lung; Male; Muscles; Protein Binding; Rats; Rats, Wistar; Tissue Distribution | 1992 |
Comparative antibacterial activity of the penem ALP 201.
Topics: beta-Lactamases; Carbapenems; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Microbial Sensitivity Tests; Streptococcaceae | 1991 |
Structures of the alkaline hydrolysis products of penem antibiotic, SUN5555.
Topics: Carbapenems; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Hydrolysis; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure | 1990 |
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1989 |
Susceptibility of anaerobic bacteria to ALP 201.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Culture Media; Microbial Sensitivity Tests | 1989 |
Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Carbapenems; Carrier Proteins; Escherichia coli; Hexosyltransferases; Hydrogen-Ion Concentration; Hydrolysis; Lactams; Microbial Sensitivity Tests; Molecular Structure; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding | 1989 |
Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.
Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1995 |
Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carbapenems; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; United States | 1995 |
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteria.
Topics: Bacteria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefaclor; Cefixime; Cefmenoxime; Cefotaxime; Drug Stability; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Microbial Sensitivity Tests | 1994 |
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Microbial Sensitivity Tests | 1994 |
Novel carbon-carbon bond cleavage reaction of penem antibiotic by class C beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromatography, High Pressure Liquid; Citrobacter freundii; Enterobacter cloacae; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrophotometry, Ultraviolet; Substrate Specificity | 1994 |
Comparative in vitro activity of furopenem against aerobic bacteria isolated from pediatric patients.
Topics: Bacteria, Aerobic; Carbapenems; Cephalosporins; Child, Preschool; Humans; Microbial Sensitivity Tests; Penicillins | 1995 |
The in-vitro activity of faropenem, a novel oral penem.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydrolysis; Microbial Sensitivity Tests | 1997 |